Planet 13 Holdings (PLNH) Change in Accured Expenses (2022 - 2026)

Planet 13 Holdings' (PLNH) quarterly Change in Accured Expenses came in at -$1.4 million in Q1 2026, down 1682.93% year-on-year from $86673.0 in Q1 2025, and down 237.01% on a QoQ basis from -$407100.0 in Q3 2025.

Planet 13 Holdings (PLNH) Change in Accured Expenses (2022 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 5 years of Change in Accured Expenses data on file, last reported at -$1.4 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 1682.93% year-over-year to -$1.4 million in Q1 2026; TTM through Mar 2026 was -$1.4 million, a 27.75% increase from a year earlier, with the FY2024 full-year figure at -$2.9 million, down 50.95% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$1.4 million, down from -$407100.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for PLNH reached as high as $1.9 million in Q4 2022 and fell as low as -$3.7 million in Q4 2024.
  • Historically, Change in Accured Expenses has averaged -$347332.9 across 5 years, with a median of -$300374.5 in 2023.
  • On a YoY basis, Change in Accured Expenses climbed as much as 194.14% in 2024 and fell as far as 1796.43% in 2024.
  • Year by year, Change in Accured Expenses stood at $1.9 million in 2022, then sank by 110.0% to -$193649.0 in 2023, then tumbled by 1796.43% to -$3.7 million in 2024, then surged by 88.91% to -$407100.0 in 2025, then slumped by 237.01% to -$1.4 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$1.4 million in Q1 2026, -$407100.0 in Q3 2025, and $318755.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.69 Bn 87.82 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.60 Bn 30.66 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.53 Bn 23.47 Bn 4.39 Bn -
5 United Therapeutics 23.06 Bn 20.91 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.32 Bn 18.52 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Planet 13 Holdings 39.32 Mn 23.06 Mn 9.41 Mn -1.37 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.37 Mn
Mar 31, 2026 -1.37 Mn
Sep 30, 2025 -407,100.00
Sep 30, 2025 -407,100.00
Jun 30, 2025 318,755.00
Jun 30, 2025 318,755.00
Mar 31, 2025 86,673.00
Mar 31, 2025 86,673.00
Dec 31, 2024 -3.67 Mn
Dec 31, 2024 -3.67 Mn
Sep 30, 2024 632,052.00
Sep 30, 2024 632,052.00
Jun 30, 2024 1.05 Mn
Jun 30, 2024 1.05 Mn
Mar 31, 2024 -956,061.00
Mar 31, 2024 -956,061.00
Dec 31, 2023 -193,649.00
Dec 31, 2023 -193,649.00
Sep 30, 2023 -671,400.00
Sep 30, 2023 -671,400.00